Current and future use of positron emission tomography (PET) in breast cancer

被引：12
|
作者：
Mankoff, David A.
Eubank, William B.
机构：
[1] UWMC, Div Nucl Med, Seattle, WA 98195 USA
[2] Univ Washington, Div Nucl Med, Dept Radiol, Seattle, WA 98195 USA
[3] Seattle Canc Care Alliance, Seattle, WA 98195 USA
[4] Puget Sound VA Hlth Care Syst, Seattle, WA USA
来源：
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA | 2006年 / 11卷 / 02期
关键词：
PET; breast cancer; imaging; molecular imaging; response evaluation;
D O I：
10.1007/s10911-006-9019-z
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Positron emission tomography (PET) is a radiotracer imaging method that is increasingly used in both the clinical care of breast cancer patients and in translational breast cancer research. This review emphasizes current and future clinical applications of PET to breast cancer, and highlights some translational research using PET to elucidate the clinical biology of breast cancer. PET principles are reviewed, followed by a review of current applications of F-18-fluorodeoxyglucose (FDG) to clinical breast cancer care. Finally we review work done with other radiopharmaceuticals beyond FDG designed to image a number of aspects of breast cancer biology, emphasizing those most likely to enter clinical trials in the near future.
引用
收藏
页码：125 / 136
页数：12
相关论文
共 50 条
  • [41] Diagnostic performance of dedicated breast positron emission tomography
    Hashimoto, Rikako
    Akashi-Tanaka, Sadako
    Watanabe, Chie
    Masuda, Hiroko
    Taruno, Kanae
    Takamaru, Tomoko
    Ide, Yoshimi
    Kuwayama, Takashi
    Kobayashi, Yasuhiro
    Takimoto, Masafumi
    Nakamura, Seigo
    BREAST CANCER, 2022, 29 (06) : 1013 - 1021
  • [42] Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives
    Visvikis, D.
    Ell, P. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) : S106 - S116
  • [43] The current status of positron emission mammography in breast cancer diagnosis
    Vasileios Kalles
    George C. Zografos
    Xeni Provatopoulou
    Dimitra Koulocheri
    Antonia Gounaris
    Breast Cancer, 2013, 20 : 123 - 130
  • [44] Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects
    Lu, Ren-Cai
    She, Bo
    Gao, Wen-Tao
    Ji, Yun-Hai
    Xu, Dong-Dong
    Wang, Quan-Shi
    Wang, Shao-Bo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (32) : 4682 - 4695
  • [45] Positron emission tomography in breast cancer: 18F- FDG and other radiopharmaceuticals
    Iakovou I.
    Giannoula E.
    Gkantaifi A.
    Levva S.
    Frangos S.
    European Journal of Hybrid Imaging, 2 (1):
  • [46] The current status of positron emission mammography in breast cancer diagnosis
    Kalles, Vasileios
    Zografos, George C.
    Provatopoulou, Xeni
    Koulocheri, Dimitra
    Gounaris, Antonia
    BREAST CANCER, 2013, 20 (02) : 123 - 130
  • [47] Current status and future needs for standards of radionuclides used in positron emission tomography
    Zimmerman, B. E.
    APPLIED RADIATION AND ISOTOPES, 2013, 76 : 31 - 37
  • [48] Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives
    D. Visvikis
    P. J. Ell
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S106 - S116
  • [49] Positron emission tomography (PET) and PET-CT in renal, bladder and prostate cancer: Update
    Delgado Bolton, Roberto C.
    Mucientes Rasilla, Jorge
    Perez Castejon, Maria Jesus
    Carreras Delgado, Jose L.
    ACTAS UROLOGICAS ESPANOLAS, 2009, 33 (01): : 11 - 23
  • [50] Application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part I. Diagnosis of breast cancer prior to treatment
    Jodlowska, Elzbieta
    Czepczynski, Rafal
    Wyszomirska, Anna
    Jarzabek, Grazyna
    Kedzia, Witold
    Ruchala, Marek
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2016, 20 (01): : 8 - 12
12345